UBS Group AG - BEAM THERAPEUTICS INC ownership

BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 230 filers reported holding BEAM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.22 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS Group AG ownership history of BEAM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,871,522
-29.3%
119,398
-6.1%
0.00%0.0%
Q2 2023$4,061,688
+148.9%
127,206
+138.7%
0.00%0.0%
Q1 2023$1,631,587
-69.9%
53,285
-61.6%
0.00%
-50.0%
Q4 2022$5,424,752
+1294.5%
138,705
+1600.0%
0.00%
Q3 2022$389,000
-74.6%
8,159
-79.4%
0.00%
-100.0%
Q2 2022$1,531,000
-59.4%
39,552
-39.9%
0.00%0.0%
Q1 2022$3,768,000
+22.5%
65,758
+70.4%
0.00%0.0%
Q4 2021$3,075,000
-27.5%
38,584
-20.9%
0.00%0.0%
Q3 2021$4,241,000
+13.7%
48,751
+68.3%
0.00%0.0%
Q2 2021$3,729,000
-47.1%
28,970
-67.1%
0.00%
-50.0%
Q1 2021$7,054,000
+297.2%
88,129
+305.1%
0.00%
+100.0%
Q4 2020$1,776,000
+1514.5%
21,756
+387.7%
0.00%
Q3 2020$110,000
-45.8%
4,461
-38.3%
0.00%
Q2 2020$203,000
+1350.0%
7,235
+804.4%
0.00%
Q1 2020$14,0008000.00%
Other shareholders
BEAM THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
MWG Management Ltd. 2,362,635$304,095,00029.88%
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 224,391$28,881,00022.15%
HSG Holding Ltd 796,089$102,465,0007.14%
DC Investments Management, LLC 21,010$2,704,0006.36%
PATHWAY CAPITAL MANAGEMENT, LP 112,197$14,441,0005.74%
Redmile Group, LLC 2,052,506$264,178,0003.91%
Casdin Capital, LLC 818,820$105,390,0002.68%
Darwin Global Management, Ltd. 126,985$16,344,0002.64%
Evolutionary Tree Capital Management, LLC 44,032$5,667,0002.61%
HHLR ADVISORS, LTD. 1,845,753$237,567,0002.44%
View complete list of BEAM THERAPEUTICS INC shareholders